辰欣药业 - Financials

辰欣药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	4.0B	4.5B	4.1B	3.8B	3.7B	4.1B	3.8B	3.0B	2.6B	2.5B	2.4B	2.2B	2.1B	1.5B
Revenue Growth %	-10.8%	9.7%	7.5%	3.0%	-10.7%	8.0%	28.5%	15.5%	2.7%	4.6%	8.3%	7.5%	34.0%	--
Total Revenue	4.0B	4.5B	4.1B	3.8B	3.7B	4.1B	3.8B	3.0B	2.6B	2.5B	2.4B	2.2B	2.1B	1.5B
Cost Of Revenue	1.7B	1.8B	1.8B	1.7B	1.6B	1.8B	1.6B	1.4B	1.5B	1.6B	1.5B	1.4B	1.2B	921.0M
+Gross Profit	2.3B	2.6B	2.3B	2.1B	2.1B	2.4B	2.2B	1.5B	1.1B	921.0M	866.0M	805.0M	838.0M	610.0M
Gross Margin %	56.6%	58.8%	56.0%	55.5%	57.2%	57.4%	57.4%	51.1%	41.6%	36.9%	36.3%	36.5%	40.8%	39.8%
Total Operating Cost	3.5B	3.9B	3.7B	3.6B	3.3B	3.6B	3.3B	2.6B	2.3B	2.2B	2.1B	2.0B	1.7B	1.3B
Selling Expenses	1.1B	1.3B	1.3B	1.2B	1.2B	1.3B	1.1B	761.0M	470.0M	342.0M	331.0M	328.0M	307.0M	198.0M
Admin Expenses	301.0M	292.0M	260.0M	230.0M	182.0M	199.0M	163.0M	152.0M	250.0M	247.0M	241.0M	224.0M	167.0M	122.0M
Rd Expenses	343.0M	375.0M	335.0M	334.0M	310.0M	311.0M	326.0M	142.0M	--	--	--	--	--	--
Finance Expenses	-32.5M	-33.7M	-27.9M	-9.1M	3.4M	-2.5M	681,800	-322,700	3.2M	8.2M	6.6M	5.4M	-781,000	-670,200
+Operating Income	572.0M	593.0M	365.0M	334.0M	485.0M	583.0M	566.0M	416.0M	270.0M	270.0M	242.0M	208.0M	326.0M	270.0M
Operating Margin %	14.4%	13.3%	9.0%	8.8%	13.2%	14.2%	14.9%	14.0%	10.5%	10.8%	10.1%	9.4%	15.9%	17.6%
Non Operating Income	4.9M	6.2M	6.0M	4.8M	3.4M	5.5M	3.5M	7.6M	19.6M	20.1M	17.3M	32.1M	9.2M	10.4M
Non Operating Expenses	1.2M	2.9M	4.4M	3.1M	3.6M	6.1M	1.1M	1.2M	672,600	4.7M	2.4M	947,600	334,800	2.9M
Investment Income	62.3M	44.1M	18.7M	72.5M	73.4M	52.2M	47.3M	6.9M	-10.0M	769,900	-9.5M	-3.8M	-907,400	-855,000
Fair Value Change Income	10.5M	-10.4M	-3.1M	-6.1M	23.0M	23.3M	-5.7M	--	--	--	--	--	--	--
Asset Disposal Income	-139,500	594,300	974,700	265,800	169,100	436,700	571,300	59,900	660,100	--	--	--	--	--
Asset Impairment Loss	56.0M	73.5M	16.5M	21.3M	28.5M	21.0M	43.2M	25.8M	22.6M	34.3M	18.4M	19.1M	22.9M	9.2M
Other Income	53.1M	38.4M	29.1M	37.3M	35.4M	40.8M	23.5M	23.9M	--	--	--	--	--	--
Income Before Tax	576.0M	596.0M	366.0M	336.0M	485.0M	582.0M	568.0M	423.0M	289.0M	285.0M	256.0M	239.0M	335.0M	278.0M
Income Tax	60.8M	70.4M	13.9M	2.2M	47.2M	67.3M	64.9M	56.9M	44.6M	39.8M	37.4M	32.2M	51.5M	40.8M
+Net Income	515.0M	525.0M	352.0M	334.0M	437.0M	515.0M	503.0M	366.0M	245.0M	246.0M	219.0M	207.0M	284.0M	237.0M
Net Margin %	12.9%	11.8%	8.7%	8.8%	11.9%	12.5%	13.2%	12.4%	9.6%	9.9%	9.2%	9.4%	13.8%	15.5%
Net Income Attributable	509.0M	521.0M	350.0M	334.0M	439.0M	515.0M	504.0M	367.0M	247.0M	247.0M	220.0M	208.0M	284.0M	237.0M
Minority Interest	6.0M	4.1M	2.3M	-244,600	-1.4M	213,400	-490,600	-1.5M	-2.3M	-1.2M	-1.2M	-1.3M	--	-2,700
Eps Basic	1.12	1.15	0.77	0.74	0.97	1.14	1.11	0.97	0.70	0.70	0.62	0.59	0.80	0.68
Eps Diluted	1.12	1.15	0.77	0.74	0.97	1.14	1.11	0.97	0.70	0.70	0.62	--	--	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	1.2B	983.0M	998.0M	939.0M	661.0M	382.0M	346.0M	1.4B	430.0M	209.0M	18.6M	17.7M	178.0M	143.0M
Trading Financial Assets	1.3B	1.6B	1.6B	1.5B	1.9B	2.0B	14.3M	20.0M	--	--	--	--	--	--
Accounts Receivable	629.0M	741.0M	716.0M	508.0M	499.0M	605.0M	509.0M	442.0M	387.0M	306.0M	234.0M	201.0M	147.0M	92.6M
Notes Receivable	457.0M	473.0M	473.0M	427.0M	--	--	202.0M	181.0M	191.0M	87.1M	138.0M	154.0M	177.0M	177.0M
Notes And Accounts Receivable	1.1B	1.2B	1.2B	935.0M	499.0M	605.0M	712.0M	624.0M	578.0M	393.0M	372.0M	356.0M	323.0M	270.0M
Prepayments	90.0M	116.0M	87.4M	34.5M	87.6M	50.8M	24.0M	19.4M	12.9M	18.7M	22.4M	92.8M	77.9M	64.0M
Inventory	810.0M	708.0M	580.0M	595.0M	572.0M	601.0M	662.0M	573.0M	322.0M	447.0M	354.0M	378.0M	398.0M	294.0M
Total Current Assets	5.0B	5.0B	4.7B	4.1B	4.0B	3.8B	3.6B	3.1B	1.5B	1.2B	806.0M	857.0M	1.0B	777.0M
Long Term Equity Investment	5.4M	5.9M	24.7M	25.6M	43.1M	42.9M	47.1M	45.4M	47.9M	58.6M	68.0M	77.5M	81.4M	49.0M
Fixed Assets	--	1.3B	1.3B	1.4B	1.1B	1.0B	1.1B	1.2B	1.1B	1.2B	1.1B	947.0M	657.0M	331.0M
Fixed Assets Total	1.1B	1.3B	1.3B	1.4B	1.1B	1.0B	1.1B	1.2B	1.1B	1.2B	1.1B	947.0M	657.0M	331.0M
Construction In Progress	--	66.7M	207.0M	200.0M	582.0M	309.0M	199.0M	141.0M	322.0M	305.0M	422.0M	268.0M	188.0M	317.0M
Construction In Progress Total	406.0M	66.7M	207.0M	200.0M	582.0M	309.0M	199.0M	141.0M	322.0M	305.0M	422.0M	268.0M	188.0M	317.0M
Intangible Assets	204.0M	212.0M	213.0M	211.0M	208.0M	208.0M	189.0M	189.0M	188.0M	188.0M	190.0M	171.0M	83.7M	85.4M
Long Term Deferred Expenses	471,200	1.9M	3.9M	2.0M	--	--	182,700	402,000	621,300	840,600	1.3M	1.2M	949,500	--
Total Non Current Assets	2.6B	2.4B	2.1B	2.2B	2.2B	1.8B	1.7B	1.7B	1.8B	1.9B	1.9B	1.5B	1.0B	797.0M
Total Assets	7.6B	7.3B	6.8B	6.4B	6.2B	5.5B	5.2B	4.7B	3.3B	3.0B	2.7B	2.4B	2.1B	1.6B
Short Term Borrowings	72.0M	34.8M	57.8M	130.0M	330.0M	100.0M	--	--	90.0M	150.0M	150.0M	100.0M	100.0M	--
Accounts Payable	404.0M	401.0M	415.0M	435.0M	425.0M	361.0M	362.0M	381.0M	353.0M	440.0M	398.0M	336.0M	185.0M	117.0M
Advance Receipts	--	--	--	--	--	84.7M	102.0M	85.5M	68.9M	58.9M	68.6M	49.6M	69.1M	67.3M
Contract Liabilities	78.1M	100.0M	119.0M	70.1M	70.5M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.5B	1.4B	1.3B	1.2B	1.3B	886.0M	1.0B	919.0M	736.0M	851.0M	703.0M	559.0M	453.0M	226.0M
Long Term Borrowings	7.7M	128.0M	100.0M	--	--	--	--	--	160.0M	--	--	--	--	--
Total Non Current Liabilities	78.0M	201.0M	177.0M	89.2M	79.4M	74.4M	85.4M	98.7M	247.0M	84.3M	89.4M	77.7M	17.2M	4.0M
Total Liabilities	1.6B	1.6B	1.5B	1.3B	1.4B	960.0M	1.1B	1.0B	982.0M	935.0M	792.0M	636.0M	470.0M	230.0M
Paid In Capital	453.0M	453.0M	453.0M	453.0M	453.0M	453.0M	453.0M	453.0M	353.0M	353.0M	353.0M	353.0M	321.0M	321.0M
Capital Reserve	1.9B	1.9B	1.9B	1.9B	1.8B	1.9B	1.9B	1.9B	871.0M	871.0M	871.0M	871.0M	903.0M	903.0M
Surplus Reserve	227.0M	227.0M	227.0M	227.0M	227.0M	227.0M	213.0M	172.0M	139.0M	112.0M	86.7M	62.7M	40.6M	12.0M
Retained Earnings	3.3B	3.1B	2.8B	2.5B	2.3B	2.0B	1.6B	1.2B	932.0M	761.0M	588.0M	437.0M	319.0M	108.0M
Minority Equity	37.4M	39.1M	23.6M	750,500	995,100	1.2M	1.0M	1.5M	3.0M	992,000	2.2M	1.7M	--	--
Equity Attributable	6.0B	5.7B	5.3B	5.1B	4.8B	4.6B	4.2B	3.7B	2.3B	2.1B	1.9B	1.7B	1.6B	1.3B
Total Equity	6.0B	5.8B	5.4B	5.1B	4.8B	4.6B	4.2B	3.7B	2.3B	2.1B	1.9B	1.7B	1.6B	1.3B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	3.4B	3.8B	3.4B	3.2B	3.2B	3.6B	3.5B	2.1B	1.7B	1.4B	1.2B	1.2B	1.2B	1.0B
Tax Refunds Received	437,000	1.3M	6.1M	1.9M	--	991,600	--	--	--	1.4M	--	--	--	--
Total Operating Cash Inflow	3.5B	3.9B	3.5B	3.3B	3.4B	3.7B	3.5B	2.2B	1.7B	1.4B	1.3B	1.3B	1.2B	1.1B
Cash Paid For Goods	811.0M	1.0B	990.0M	850.0M	850.0M	1.1B	1.1B	461.0M	428.0M	362.0M	398.0M	316.0M	378.0M	436.0M
Cash Paid To Employees	457.0M	433.0M	382.0M	357.0M	294.0M	274.0M	241.0M	225.0M	194.0M	209.0M	177.0M	171.0M	155.0M	98.8M
Taxes Paid	390.0M	434.0M	363.0M	393.0M	285.0M	412.0M	478.0M	368.0M	299.0M	223.0M	204.0M	186.0M	182.0M	167.0M
Total Operating Cash Outflow	3.0B	3.4B	3.2B	3.1B	2.9B	3.5B	3.1B	1.8B	1.4B	1.2B	1.2B	1.2B	1.2B	989.0M
Operating Cash Flow	571.0M	451.0M	258.0M	234.0M	431.0M	181.0M	407.0M	440.0M	292.0M	266.0M	27.5M	81.3M	33.1M	76.3M
Total Investing Cash Inflow	1.9B	2.4B	2.7B	4.6B	6.5B	6.3B	54.6M	52.0M	18.2M	23.8M	23.7M	66.8M	10.9M	5.1M
Total Investing Cash Outflow	1.9B	2.8B	3.0B	4.3B	6.5B	6.4B	1.4B	354.0M	102.0M	79.7M	48.7M	228.0M	74.9M	131.0M
Investing Cash Flow	-21.7M	-378.0M	-273.0M	327.0M	-47.0M	-145.0M	-1.4B	-302.0M	-84.3M	-55.9M	-25.0M	-161.0M	-64.0M	-126.0M
Cash From Borrowings	53.3M	54.0M	250.0M	138.0M	330.0M	100.0M	--	200.0M	310.0M	300.0M	150.0M	118.0M	200.0M	--
Dividends And Interest Paid	307.0M	160.0M	151.0M	121.0M	280.0M	119.0M	71.8M	53.3M	55.9M	55.2M	53.3M	74.7M	45.3M	23.9M
Debt Repayments	133.0M	55.5M	230.0M	338.0M	100.0M	--	--	450.0M	210.0M	300.0M	100.0M	118.0M	100.0M	--
Total Financing Cash Inflow	81.2M	85.0M	491.0M	143.0M	386.0M	100.0M	2.7M	1.3B	314.0M	300.0M	152.0M	123.0M	263.0M	158.0M
Total Financing Cash Outflow	446.0M	219.0M	383.0M	461.0M	470.0M	119.0M	71.8M	515.0M	266.0M	355.0M	153.0M	193.0M	207.0M	33.5M
Financing Cash Flow	-365.0M	-134.0M	108.0M	-318.0M	-84.0M	-19.0M	-69.1M	816.0M	48.4M	-55.2M	-1.6M	-70.2M	56.0M	124.0M
Net Change In Cash	185.0M	-60.0M	94.1M	242.0M	297.0M	17.6M	-1.0B	953.0M	256.0M	155.0M	910,700	-150.0M	25.1M	74.9M
Ending Cash Balance	1.1B	936.0M	996.0M	902.0M	659.0M	362.0M	344.0M	1.4B	430.0M	174.0M	18.6M	17.7M	168.0M	143.0M
Capex	102.0M	17.7M	35.2M	51.0M	202.0M	103.0M	40.4M	24.0M	42.4M	19.1M	48.7M	225.0M	28.9M	131.0M